S079p

VENTURE CAPITAL
Baird Capital
www.bairdcapital.com
425 N. Main Street
Ann Arbor, MI 48104
HEADQUARTERS:
227 West Monroe Street, Suite 1900
Chicago, IL 60606
Staff:
JIM PAVLIK - Partner
jpavlik@rwbaird.com
BENEDICT ROCCHIO - Partner
brocchio@rwbaird.com
MIKE LIANG – Partner
mliang@rwbaird.com
NICOLE WALKER - Principal
nwalker@rwbaird.com
DAVE GREGORKA - Venture Partner
dgregorka@rwbaird.com
Michigan Investment Professionals: 1
Worldwide Investment Professionals: 60
Assets Under Management:
$3,100,000,000
Funds Managed (Current and Historical): 13
Actively Investing? Yes
Firm Overview:
Baird Capital makes venture capital, growth equity and private equity
investments in strategically targeted sectors around the world.
Baird Capital’s venture team invests in early and expansion stage
technology-enabled services and healthcare companies. Having
invested in more than 285 companies over its history, Baird Capital
partners with entrepreneurs and leverages its executive networks
to strive to build exceptional companies. The venture team has
partnered with many of today’s leading emerging businesses in the
targeted sectors, including such companies as Accuri Cytometers,
Interlace Medical, Molecular Imaging and NeuMoDx.
Industry Sectors:
M E M B E R
Life Information Alternative Adv Materials Business Consumer
Sciences Technology Energy Media & Manufacturing Services Products Other
Beringea
www.beringea.com
HEADQUARTERS:
32330 W. 12 Mile Road
Farmington Hills, MI 48334
Staff:
CHARLIE ROTHSTEIN - Founder, Senior Managing Director
crothstein@beringea.com
MICHAEL GROSS - Managing Director
mgross@beringea.com
Michigan Investment Professionals: 5
Worldwide Investment Professionals: 17
Assets Under Management:
$550,000,000
Funds Managed (Current and Historical): 9
Actively Investing? Yes
Firm Overview:
Beringea is a private equity firm providing growth capital to
market-leading businesses. The Firm’s team offers portfolio
companies the resources to grow their businesses and create value
for shareholders. Beringea invests $2-$15 million in equity and/
or subordinated debt in companies seeking capital for business
expansions and growth, ownership transitions, leveraged buyouts,
recapitalizations and refinancings.
Preferred Initial Investment Amount:
$3,000,000
Industry Sectors:
Life Information Alternative Adv Materials Business Consumer
Sciences Technology Energy Media & Manufacturing Services Products Other
Life Science Subsector:
Healthcare Animal Health/
Pharmaceuticals Devices Diagnostics Biotechnology Services Agriculture Other
Information Technology Subsector:
Hardware Software Services Other
M E M B E R
Life Science Subsector:
Healthcare Animal Health/
Pharmaceuticals Devices Diagnostics Biotechnology Services Agriculture Other
Stages of Investment:
Idea & Pre-Seed Seed Early Growth Mezzanine
Information Technology Subsector:
Hardware Software Services Other
Stages of Investment:
Idea & Pre-Seed Seed Early Growth Mezzanine
DENOTES MICHIGAN SEATED
Portfolio & Firm Highlights:
1 In addition to providing flexible capital solutions, Beringea
leverages its U.S. and UK footprint to offer portfolio companies an
international perspective and access to new international markets.
2 Beringea founder and senior managing director Charlie Rothstein is
a board member of Venture Michigan Funds I and II, funds-of-funds
targeting Michigan-based venture capital firms. Previously, he served
for several years as a board member of Michigan Strategic Fund, one of
the State’s leading economic development and finance authorities.
17